BMEA — BIOMEA FUSION INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About BIOMEA FUSION INC (BMEA)
BIOMEA FUSION INC (BMEA) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $1M. Across recent filings, tracked investors recorded 5 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BMEA
How many top investors track BMEA
A small number of top investors own this.
BMEA Ownership Composition
How BIOMEA FUSION INC is held across tracked investor types, based on reported 13F positions.
- Other98.5%
- Hedge Funds1.5%
Tracked investors reporting BMEA
- Ken GriffinMar 31, 2026Citadel AdvisorsShares903.7KValue$1.4M% Portfolio0.00%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares18.3KValue$28.1K% Portfolio0.00%
- Steve CohenDec 31, 2025Point72 Asset ManagementShares17.3KValue$21.4K% Portfolio0.00%
Recent activity
- $31.8KFeb 17, 2026
- $28.1KMay 15, 2026
- New$21.4KFeb 17, 2026
- New$1.4MMay 15, 2026
- New$960.4KNov 14, 2025
Frequently asked questions
- How many institutional investors hold BMEA?
- 3 tracked institutional investors disclosed a position in BMEA (BIOMEA FUSION INC) in their most recent 13F filing.
- Who is the largest institutional holder of BMEA?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in BMEA, valued at $1M.
- Did institutional ownership of BMEA increase or decrease?
- Across recent 13F filings, tracked investors recorded 5 new positions, 0 increased, 0 reduced, and 0 fully exited BMEA.
- Where does this BMEA ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.